期刊文献+

喹诺酮类药物半衰期的定量构动关系研究

Quantitative Structure-Pharmacokinetic Relationship of Quinolones Half Life
原文传递
导出
摘要 目的应用多元线性回归方法研究喹诺酮类药物的分子结构和半衰期间的定量构动关系(QSPR)。方法利用Hyperchem和Chemoffice软件计算了25个喹诺酮类药物的结构参数和电性参数。随机选取20个药物做训练集以建立QSPR模型,5个常用药物做检验集以检验模型的准确性。结果影响喹诺酮半衰期的主要参数EHOMO,φ3,LogP,DM4个分子描述符进入模型,模型复相关系数达0.958。检验集的计算值与实验值复相关系数达0.924。结论所建立的模型能够很好地预测喹诺酮类药物的半衰期,并有效地描述其影响因素。 OBJECTIVE To study the quantitative structure-pharmacokinetic relationship (QSPR) ofquinolones compounds between molecular structure parameters and half life(t1/2) by multivariate linear regression. METHODS Molecular descriptors of 25 quinolones compounds were calculated using hyperchem and chemoffice software 20 quinolones compounds were selected stochastically as the training set to develop the QSPR model and 5 residual was used to test the predict effect of the QSPR model. RESULTS The corresponding QSPR model containing five molecular descriptors EHOMO, φ3,LogP, DM was established with r as 0.958 of the training set and 0.924 of the test set. CONCLUSION The model have good predictive ability and can be used to study the major molecular descriptors related with t1/2 of quinolones compounds.
出处 《中国药学杂志》 CAS CSCD 北大核心 2009年第14期1097-1100,共4页 Chinese Pharmaceutical Journal
关键词 喹诺酮 半衰期 定量构动关系 quinolones half life quantitative structure-pharmacokinetic relationship
  • 相关文献

参考文献14

  • 1LIAL WANGXH LIZX.Thecontrolofprodrugandbioavailability.中国药学杂志,2001,36(1):7-10.
  • 2段东红,王秀兰,乔本志.氟喹诺酮类化合物及其衍生物构效关系研究[J].太原理工大学学报,1999,30(6):646-647. 被引量:1
  • 3MARIYANA A, SONIA I, BORIS G. QSAR analysis of 1, 4-dihydro-4-oxo-1-(2-thiazolyl)-1, 8-naphthyridines with anticancer activity[J]. Eur dr Med Chem, 2007, 42(9): 1184-1192.
  • 4RAJESHWAR P, VERMA, CORWIN H. An approach toward the problem of outliers in QSAR[J]. Bioorg Med Chem, 2005, 13(15):4597-4621.
  • 5FOUCHECOURT M O, BELIVEAU M, KRISHNAN K.Quantitative structure pharmacokinetics relationship modeling[J]. Sci Total Environ, 2001,274(1-3): 125-135.
  • 6MAYER J M, VAN DE WATERBEEMD H. Development of quantitative structure-pharmacokinetic relationships [J]. Environ HealthPerspect, 1985, 61(9): 295-306.
  • 7ZHOUL.Quantitativestructurepharmacokineticrelationshipanddrugmoleculardesign.华西药学杂志,2005,20:334-336.
  • 8XIAKH ZHOUL HAOLF.Recentstudiesonquinoloneantibiotics.国外医药:抗生素分册,2004,25(3):138-141.
  • 9MAGER D E. Quantitative structure-pharmacokinetic/ pharmaeodynamic relationships [J]. Adv Drug Deliv Rev, 2006, 58(12-13): 1326-1356.
  • 10RAMAMURTHI N, SITARAMA B G. In silico ADME modelling: prediction models for blood-brain barrier permeation using a systematic variable selection method[J]. Bioorg Med Chem, 2005, 13(8):3017-3028.

二级参考文献12

共引文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部